These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12240487)

  • 1. Nursing assessment of sexual function following permanent prostate brachytherapy for patients with early-stage prostate cancer.
    Stipetich RL; Abel LJ; Blatt HJ; Galbreath RW; Lief JH; Butler WM; Merrick GS
    Clin J Oncol Nurs; 2002; 6(5):271-4. PubMed ID: 12240487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
    Lehrer S; Cesaretti J; Stone NN; Stock RG
    BJU Int; 2006 Nov; 98(5):979-81. PubMed ID: 17034599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nursing considerations in brachytherapy-related erectile dysfunction.
    Stipetich R; Abel LJ; Anderson RL; Butler WM; Wallner KE; Merrick GS
    Urol Nurs; 2005 Aug; 25(4):249-54; quiz 259. PubMed ID: 16225341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer.
    Teloken PE; Ohebshalom M; Mohideen N; Mulhall JP
    J Urol; 2007 Dec; 178(6):2521-5. PubMed ID: 17937948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of sexual dysfunction after prostate brachytherapy.
    Merrick GS; Wallner KE; Butler WM
    Oncology (Williston Park); 2003 Jan; 17(1):52-62; discussion 62, 67-70, 73. PubMed ID: 12599931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of sildenafil citrate following radiation therapy for prostate cancer: temporal considerations.
    Ohebshalom M; Parker M; Guhring P; Mulhall JP
    J Urol; 2005 Jul; 174(1):258-62; discussion 262. PubMed ID: 15947650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Success of sildenafil for erectile dysfunction in men treated with brachytherapy or external beam radiation for prostate cancer.
    Shemtov OM; Radomski SB; Crook J
    Can J Urol; 2004 Dec; 11(6):2450-5. PubMed ID: 15636671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early intervention with phosphodiesterase-5 inhibitors after prostate brachytherapy improves subsequent erectile function.
    Pahlajani G; Raina R; Jones JS; Burdick M; Ali M; Li J; Mahadevan A; Ciezki J; Zippe C
    BJU Int; 2010 Nov; 106(10):1524-7. PubMed ID: 20477827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study.
    Stephenson RA; Mori M; Hsieh YC; Beer TM; Stanford JL; Gilliland FD; Hoffman RM; Potosky AL
    J Urol; 2005 Aug; 174(2):646-50; discussion 650. PubMed ID: 16006930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised, placebo-controlled, crossover trial of sildenafil citrate in the treatment of erectile dysfunction following external beam radiation treatment of prostate cancer.
    Harrington C; Campbell G; Wynne C; Atkinson C
    J Med Imaging Radiat Oncol; 2010 Jun; 54(3):224-8. PubMed ID: 20598010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes and quality-of-life issues for patients treated with prostate brachytherapy.
    Abel L; Dafoe-Lambie J; Butler WM; Merrick GS
    Clin J Oncol Nurs; 2003; 7(1):48-54. PubMed ID: 12629934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of brachytherapy in the treatment of localized prostate cancer. Preliminary report].
    Rodríguez Duarte C; Mattout J; Moreira O; Jiménez R
    Arch Esp Urol; 2002 Sep; 55(7):785-91. PubMed ID: 12380306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erectile function after permanent prostate brachytherapy.
    Merrick GS; Butler WM; Galbreath RW; Stipetich RL; Abel LJ; Lief JH
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):893-902. PubMed ID: 11958881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction.
    Merrick GS; Butler WM; Dorsey AT; Lief JH; Donzella JG
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1069-74. PubMed ID: 11072164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early use of a phosphodiesterase inhibitor after brachytherapy restores and preserves erectile function.
    Schiff JD; Bar-Chama N; Cesaretti J; Stock R
    BJU Int; 2006 Dec; 98(6):1255-8. PubMed ID: 17125483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potency after permanent prostate brachytherapy for localized prostate cancer.
    Potters L; Torre T; Fearn PA; Leibel SA; Kattan MW
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1235-42. PubMed ID: 11483334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
    Bradley EB; Bissonette EA; Theodorescu D
    BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction.
    Merrick GS; Wallner K; Butler WM; Galbreath RW; Lief JH; Benson ML
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):597-604. PubMed ID: 11395225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erectile function outcome reporting after clinically localized prostate cancer treatment.
    Burnett AL; Aus G; Canby-Hagino ED; Cookson MS; D'Amico AV; Dmochowski RR; Eton DT; Forman JD; Goldenberg SL; Hernandez J; Higano CS; Kraus S; Liebert M; Moul JW; Tangen C; Thrasher JB; Thompson I;
    J Urol; 2007 Aug; 178(2):597-601. PubMed ID: 17570435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual function after permanent 125I-brachytherapy for prostate cancer.
    Mabjeesh N; Chen J; Beri A; Stenger A; Matzkin H
    Int J Impot Res; 2005; 17(1):96-101. PubMed ID: 15510186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.